Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.38 -0.18 (-5.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bicycle Therapeutics (BCYC) Selling, General & Administrative (2018 - 2026)

Updated

Bicycle Therapeutics' Selling, General & Administrative came in at $14.03 million for Q2 2026, down 24.1% from $18.49 million a year earlier and down 19.7% from the prior quarter.

Analysis

Bicycle Therapeutics (BCYC) Selling, General & Administrative (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bicycle Therapeutics reported Selling, General & Administrative of $71.25 million, down 10.3% year-over-year; for FY2025, it came in at $79.37 million, up 10.0% from FY2024.

  • Selling, General & Administrative has increased in each of the last eight years, with a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $72.18 million in FY2024 (+19.5%), $60.43 million in FY2023 (+22.1%), $49.51 million in FY2022 (+52.6%) and $32.44 million in FY2021 (+11.1%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q4 2022.
  • Year-over-year, Selling, General & Administrative has declined for three consecutive quarters, with growth averaging 7.6% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2022 (growth of 108.4%), and the weakest in Q2 2026 (a decline of 24.1%).
  • Business Quant data shows BCYC's Selling, General & Administrative at $17.47 million (Q1 2026), $20.89 million (Q4 2025) and $18.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Bicycle Therapeutics 248.54 Mn 248.54 Mn - 14.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.03 Mn
Mar 31, 2026 17.47 Mn
Dec 31, 2025 20.89 Mn
Sep 30, 2025 18.86 Mn
Jun 30, 2025 18.49 Mn
Mar 31, 2025 21.12 Mn
Dec 31, 2024 21.59 Mn
Sep 30, 2024 18.26 Mn
Jun 30, 2024 15.95 Mn
Mar 31, 2024 16.38 Mn
Dec 31, 2023 14.87 Mn
Sep 30, 2023 16.28 Mn
Jun 30, 2023 14.79 Mn
Mar 31, 2023 14.49 Mn
Dec 31, 2022 10.68 Mn
Sep 30, 2022 10.05 Mn
Jun 30, 2022 11.82 Mn
Mar 31, 2022 16.96 Mn
Dec 31, 2021 8.84 Mn
Sep 30, 2021 8.11 Mn
API Access

Bicycle Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCYC&period=max&api_key=YOUR_API_KEY